- Tablets
- Capsules
- Powders & Granules
- Lozenges & Pastilles
- Gummies
Contract Manufacturing of Oral Solids Market size was valued at USD 35.01 billion in 2023 and poised to grow at a CAGR of 5.1% during the forecast period 2024 to 2030 owing to increase in outsourcing by the innovator companies on branded products results in approximately 40% to 60 % cost savings to the company and are expected to drive the growth of the market. Moreover, increasing number of contract manufacturing organizations coupled advanced manufacturing technologies fuels the growth of the market. However, high supplier switching cost and risks related to data confidentiality and exclusivity are expected to hamper the growth of the market. The report studies global contract manufacturing of oral solids market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. global contract manufacturing of oral solids market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
Contract Manufacturing Of Oral Solids Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.1%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Contract Manufacturing of Oral Solids Market Dynamics
In contract manufacturing of oral solids, information such as product formula has to be transferred from client (innovator) companies to suppliers (CMOs) which involves the risk i.e. related to data confidentiality and exclusivity. The service provider after the completion of agreement might become the competitor for innovator for the particular product. Moreover, the buyers have to pay high switching cost to the service providers due to need for compatibility with the manufacturing equipment required that is expected to limit the growth of the contract manufacturing of oral solids market.
North-America Got Significant Share
Contract Manufacturing of Oral Solids Market Regional Analysis
North America accounted for larger revenue share in global contract manufacturing of oral solids market with significant CAGR owing to presence of large number of market players in the region and long term contract manufacturing partnerships between companies and CMOs strive hard to keep up with regulatory compliance drives the growth of the market over the forecast period. Asia Europe and Asia Pacific are expected to exhibit significant growth rate over the forecast period owing to rising number of contract manufacturing organizations and benefits that are obtained to the innovator companies such as cost cuttings up to 40% to 60% fuels the growth of the market over the future years.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The contract manufacturing of oral solids market report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
- The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
Contract Manufacturing Of Oral Solids Market Segmentation
By Product Type
By End User
- Big Pharma or Biotechnology Companies
- Small & Medium Size Pharma/Biotech Companies
- Emerging/virtual Pharma Companies
- Nutraceutical Companies
By Geography
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
LOCATION
Geography
Frequently Asked Questions
The key segments covered in the Contract Manufacturing of Oral Solids Market are: by product type and by end user
The Contract Manufacturing of Oral Solids Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
North America is the fastest-growing for Contract Manufacturing of Oral Solids Market
| 1.Executive Summary |
| 2.Global Contract Manufacturing Of Oral Solids Market Introduction |
| 2.1.Global Contract Manufacturing Of Oral Solids Market - Taxonomy |
| 2.2.Global Contract Manufacturing Of Oral Solids Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2. End User |
| 2.2.3.Region |
| 3.Global Contract Manufacturing Of Oral Solids Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Contract Manufacturing Of Oral Solids Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Contract Manufacturing Of Oral Solids Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Tablets |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Capsules |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Powders & Granules |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Lozenges & Pastilles |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Gummies |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Contract Manufacturing Of Oral Solids Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Big Pharma or Biotechnology Companies |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Small & Medium Size Pharma/Biotech Companies |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Emerging/virtual Pharma Companies |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Nutraceutical Companies |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Contract Manufacturing Of Oral Solids Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Contract Manufacturing Of Oral Solids Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Tablets |
| 8.1.2.Capsules |
| 8.1.3.Powders & Granules |
| 8.1.4.Lozenges & Pastilles |
| 8.1.5.Gummies |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Big Pharma or Biotechnology Companies |
| 8.2.2.Small & Medium Size Pharma/Biotech Companies |
| 8.2.3.Emerging/virtual Pharma Companies |
| 8.2.4.Nutraceutical Companies |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Contract Manufacturing Of Oral Solids Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Tablets |
| 9.1.2.Capsules |
| 9.1.3.Powders & Granules |
| 9.1.4.Lozenges & Pastilles |
| 9.1.5.Gummies |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Big Pharma or Biotechnology Companies |
| 9.2.2.Small & Medium Size Pharma/Biotech Companies |
| 9.2.3.Emerging/virtual Pharma Companies |
| 9.2.4.Nutraceutical Companies |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Contract Manufacturing Of Oral Solids Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Tablets |
| 10.1.2.Capsules |
| 10.1.3.Powders & Granules |
| 10.1.4.Lozenges & Pastilles |
| 10.1.5.Gummies |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Big Pharma or Biotechnology Companies |
| 10.2.2.Small & Medium Size Pharma/Biotech Companies |
| 10.2.3.Emerging/virtual Pharma Companies |
| 10.2.4.Nutraceutical Companies |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Contract Manufacturing Of Oral Solids Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Tablets |
| 11.1.2.Capsules |
| 11.1.3.Powders & Granules |
| 11.1.4.Lozenges & Pastilles |
| 11.1.5.Gummies |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Big Pharma or Biotechnology Companies |
| 11.2.2.Small & Medium Size Pharma/Biotech Companies |
| 11.2.3.Emerging/virtual Pharma Companies |
| 11.2.4.Nutraceutical Companies |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Contract Manufacturing Of Oral Solids Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Tablets |
| 12.1.2.Capsules |
| 12.1.3.Powders & Granules |
| 12.1.4.Lozenges & Pastilles |
| 12.1.5.Gummies |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Big Pharma or Biotechnology Companies |
| 12.2.2.Small & Medium Size Pharma/Biotech Companies |
| 12.2.3.Emerging/virtual Pharma Companies |
| 12.2.4.Nutraceutical Companies |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Recipharm AB |
| 13.2.2.AbbVie Contract Manufacturing |
| 13.2.3.Patheon N.V. |
| 13.2.4.Catalent Inc. |
| 13.2.5.NextPharma |
| 13.2.6.Capsugel (Lonza Group AG) |
| 13.2.7.Aurobindo Pharma Limited (AuroSource) |
| 13.2.8.Siegfried AG |
| 13.2.9.Piramal Pharma Solutions |
| 13.2.10.CordenPharma |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Recipharm AB
- AbbVie Contract Manufacturing
- Patheon N.V.
- Catalent Inc.
- NextPharma
- Capsugel (Lonza Group AG)
- Aurobindo Pharma Limited (AuroSource)
- Siegfried AG
- Piramal Pharma Solutions
- CordenPharma